STOCK TITAN

Executive Alistair Grenfell gets 26,088 stock rights at IQVIA (IQV)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IQVIA Holdings Inc. reported that officer Alistair Grenfell received a grant of 26,088 stock appreciation rights on February 9, 2026, at an exercise price of $192.67 per right. These rights vest in three annual installments beginning on February 9, 2027, and are scheduled to expire on February 9, 2036. Following this award, Grenfell beneficially owns 26,088 derivative securities directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Grenfell Alistair

(Last) (First) (Middle)
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD

(Street)
DURHAM NC 27703

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right $192.67 02/09/2026 A 26,088 (1) 02/09/2036 Common Stock 26,088 $0 26,088 D
Explanation of Responses:
1. This stock appreciation right vests in three annual installments beginning on February 9, 2027.
Remarks:
President, Commercial Solutions
/s/ Matthew Gilmartin, Attorney-in Fact for Alistair Grenfell 02/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IQVIA (IQV) report for Alistair Grenfell?

IQVIA reported a grant of 26,088 stock appreciation rights to officer Alistair Grenfell. The award was dated February 9, 2026, and represents a direct beneficial holding of derivative securities linked to IQVIA common stock.

What type of securities were granted to Alistair Grenfell at IQVIA (IQV)?

Alistair Grenfell received a stock appreciation right award. Each right is tied to IQVIA common stock and was granted at an exercise price of $192.67, giving upside exposure without an upfront purchase of shares at the time of the grant.

How many stock appreciation rights did Alistair Grenfell receive from IQVIA (IQV)?

Alistair Grenfell received 26,088 stock appreciation rights. This full amount remains beneficially owned following the reported transaction and is held directly as a derivative position linked to IQVIA common stock.

When do Alistair Grenfell’s IQVIA (IQV) stock appreciation rights vest?

The stock appreciation rights vest in three annual installments, starting on February 9, 2027. This schedule spreads vesting over three years, aligning the executive’s incentive with IQVIA’s longer-term performance over that period.

What is the exercise price and expiration date of Grenfell’s IQVIA (IQV) stock appreciation rights?

The stock appreciation rights have an exercise price of $192.67 per right and an expiration date of February 9, 2036. This provides a long-dated incentive window tied to IQVIA’s share performance over roughly a decade.

Is Alistair Grenfell’s ownership of the IQVIA (IQV) stock appreciation rights direct or indirect?

Alistair Grenfell’s 26,088 stock appreciation rights are reported as directly owned. The filing lists his ownership form as “D” for direct, with no indication of an intermediate entity or indirect beneficial ownership structure.
Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Latest SEC Filings

IQV Stock Data

28.31B
167.90M
1.05%
102.1%
2.9%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM